"Tranexamic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antifibrinolytic hemostatic used in severe hemorrhage.
| Descriptor ID |
D014148
|
| MeSH Number(s) |
D02.241.223.268.860
|
| Concept/Terms |
Tranexamic Acid- Tranexamic Acid
- AMCHA
- trans-4-(Aminomethyl)cyclohexanecarboxylic Acid
- t-AMCHA
- AMCA
|
Below are MeSH descriptors whose meaning is more general than "Tranexamic Acid".
Below are MeSH descriptors whose meaning is more specific than "Tranexamic Acid".
This graph shows the total number of publications written about "Tranexamic Acid" by people in this website by year, and whether "Tranexamic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tranexamic Acid" by people in Profiles.
-
Strauss ER, Li S, Henderson R, Carpenter R, Guo D, Thangaraju K, Katneni U, Buehler PW, Gobburu JVS, Tanaka KA. A Pharmacokinetic and Plasmin-Generation Pharmacodynamic Assessment of a Tranexamic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2022 Aug; 36(8 Pt A):2473-2482.
-
Steinmetz RG, Luick L, Tkach S, Falcon S, Stoner J, Hollabaugh K, Ringus V, Haleem AM. Effect of Tranexamic Acid on Wound Complications and Blood Loss in Total Ankle Arthroplasty. Foot Ankle Int. 2020 Sep; 41(9):1117-1121.
-
O'Brien SH, Saini S, Ziegler H, Christian-Rancy M, Ahuja S, Hege K, Savelli SL, Vesely SK. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2019 Jun; 32(3):305-311.
-
Fischer PE, Bulger EM, Perina DG, Delbridge TR, Gestring ML, Fallat ME, Shatz DV, Doucet J, Levy M, Stuke L, Zietlow SP, Goodloe JM, VanderKolk WE, Fox AD, Sanddal ND. Guidance Document for the Prehospital Use of Tranexamic Acid in Injured Patients. Prehosp Emerg Care. 2016 Sep-Oct; 20(5):557-9.
-
Silvetti S, Crivellari M, Castiglioni A, Landoni G, Zangrillo A, Alfieri O, Koster A, Faraoni D, Bolliger D, Tanaka KA. CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin. J Cardiothorac Vasc Anesth. 2016 Dec; 30(6):1709-1715.
-
Harvin JA, Peirce CA, Mims MM, Hudson JA, Podbielski JM, Wade CE, Holcomb JB, Cotton BA. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg. 2015 May; 78(5):905-9; discussion 909-11.
-
Goodloe JM, Gerecht R. TXA in the USA. Tranexamic acid's potentially bright future relies on collaborative data. JEMS. 2015 Apr; 40(4):30-5.
-
Goodloe JM, Howerton DS, McAnallen D, Reed H. How can tranexamic acid help in EMS? TXA offers new hope for an old challenge in traumatic hemorrhagic shock. EMS World. 2013 May; 42(5):I5-6.
-
Goodloe JM, Howerton DS, McAnallen D, Reed H. TXA: a difference-maker for trauma patients. JEMS. 2013 Apr; 38(4):60-5.
-
Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, Tanaka KA. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):959-63.